EXHIBIT ANeurobiological Technologies Inc /Ca/ • December 29th, 1999 • Biological products, (no disgnostic substances) • California
Company FiledDecember 29th, 1999 Industry Jurisdiction
THE SECURITIES OFFERED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND HAVE BEEN TAKEN FOR INVESTMENT PURPOSES ONLY AND NOT WITH A VIEW TO OR FOR SALE IN CONNECTION...Neurobiological Technologies Inc /Ca/ • December 29th, 1999 • Biological products, (no disgnostic substances) • California
Company FiledDecember 29th, 1999 Industry Jurisdiction
July 8, 1999 Neurobiological Technologies, Inc. 1387 Marina Way South Richmond, California 94804 Gentlemen: This letter sets forth our agreement whereby AmeriCal Securities, Inc. ("AmeriCal") will act as exclusive placement agent for Neurobiological...Neurobiological Technologies Inc /Ca/ • December 29th, 1999 • Biological products, (no disgnostic substances) • California
Company FiledDecember 29th, 1999 Industry JurisdictionThis letter sets forth our agreement whereby AmeriCal Securities, Inc. ("AmeriCal") will act as exclusive placement agent for Neurobiological Technologies, Inc. (the "Company") for the offer and sale of units ("Units") of common stock and warrants to purchase common stock of the Company for a gross purchase price not to exceed $2,000,000 as more particularly outlined in the attached term sheet (the "Term Sheet"). It is understood that the offering shall be made pursuant to Regulation D under the Securities Act of 1933, as amended (the "Securities Act").